Bridging the gap between innovation and capital
Medtronic
Focus on Medical Devices Companies
Program
Medtronic is a global leader in healthcare technology, developing and commercializing innovative medical devices and therapies that improve patient outcomes and transform healthcare.
Event
LaunchBio, Browne Consulting, and Silicon Valley Bank, a division of First Citizens Bank, with support by Fondation Ipsen, are pleased to announce their next Investor Connect virtual event with Medtronic.
Medtronic operates across cardiovascular, neuroscience, medical surgical, and diabetes markets, serving patients in more than 150 countries worldwide and with revenues over $34B annually. The corporate development and ventures group focuses on collaboration through funding or expertise, a venture fund focused on Medtronic-adjacent markets and mergers and acquisitions of companies. The team consists of 15 professionals with deep expertise in medtech, engineering, and commercialization, with operations and offices across Minneapolis (headquarters), Boston, and New York.
Applications will be selected based on meeting the following criteria:
Geography
Open to investments anywhere in USA, Europe, Israel and China
Company type
Focus on companies with Medical Devices, Tools and Diagnostics
Modalities of Interest
- Cell therapies
- Protein-based therapies
- Drug coated balloons
- Cell therapies
- Therapies requiring specific delivery mechanism (catheter/device)
Therapeutic areas include, but are not limited to:
- Cardiology
- Gastroenterology
- Hematology
- Neurology
- Oncology
- Pulmonology
Stage
Series A, Series B, Series C
Qualifying start-ups can apply here today.
Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Browne Consulting and Silicon Valley Bank, a division of First Citizens Bank.